Skip to main content
Premium Trial:

Request an Annual Quote

Mark Wingerd New ISB Proteomics Facility Director, Eugene Davidov Director of New Yale Center for Genomics and Proteomics, Dana Hosseini Becomes CEO of Icelandic Genomics, J. Craig Venter to Chair US Genomics SAB, and Others

NEW YORK, Feb. 11 (GenomeWeb News) -- Mark Wingerd has become director of the proteomics facility at the Institute of Systems Biology, the ISB said last week. He succeeds David Goodlett, who left for a faculty position at the University of Washington. Wingerd joins the institute from Pacific Northwest National Laboratory, where he worked with Dick Smith to develop high-throughput technologies and helped establish a proteomics facility.


 

Eugene Davidov has been appointed as director of the Yale Center for Genomics and Proteomics, and Paul Fletcher as director of the center's chemical genomics screening facility, the university said this week.

 

Before coming to Yale, Davidov was a principal investigator at Beyond Genomics. Prior to that, he worked at Millennium Pharmaceuticals and Anadys Pharmaceuticals. Davidov holds a PhD in biochemistry from Clark University.

 

Fletcher joins Yale from Edison, NJ-based DGI BioTechnologies, where he was director of screening technologies. Fletcher holds a BS from the University of Delaware, an MS in biology and animal science from Clemson University, and a PhD in reproductive physiology and biochemistry from the University of Wyoming.


 

Dana Hosseini has become president and CEO of Iceland Genomics, based in Reykjavik, the company said last week. He will also become a company director. Prior to joining Iceland Genomics, he was vice president for business development at Cyntellect and director for business development at Sequenom. Hosseini holds an MBA and a BS in biology from the University of British Columbia.


 

Elizabeth Hutt has been appointed vice president of sales and service, Anne Kopf-Sill vice president of product development, and John Todd vice president of marketing for San Carlos, Calif.-based NuGen Technologies, the company said last week.

 

Hutt joins NuGen from Tripos, where she was vice president of sales and service. She also held sales management positions with Affymetrix. Hutt obtained an MS in business administration from Central Michigan University and a BA in chemistry from Michigan State University.

 

Prior to coming to NuGen, Kopf-Sill was vice president of new products at Caliper Technologies. She holds a PhD in chemical engineering from Stanford University.

 

Todd, before joining NuGen, was an independent business consultant for biotechnology firms. He obtained a PhD in biochemistry from the University of Southern California Medical Center.


 

Cynthia Stephenshas been appointed as senior vice president and CFO of Pharsight, where she has been interim CFO since last fall, the company said yesterday. Prior to joining Pharsight, Stephens was vice president of finance at Rainmaker Systems. Pharsight, which provides science and information technology-based software and consulting, is based in Mountain View, Calif.


 

J. Craig Venter will take on the role of chairman of the scientific advisory board of US Genomics, in addition to being a company director, US Genomics said today. He is currently president of the J. Craig Venter Science Foundation.

In addition, Hamilton Smith has joined the Woburn, Mass. company's scientific advisory board. He is the scientific director of the Institute for Biological Energy Alternatives and a Nobel Prize winner.


 

Charles Shank will step down as the director of Lawrence Berkeley National Laboratory by the end of the year, the laboratory said on Monday. Shank, who will remain a professor at the University of California, Berkeley, joined LBNL and the university's faculty in 1989.


 

Cheryl Wenzinger has joined the board of directors of San Diego-based Diversa, where she will serve as financial expert on the audits committee, the company said today. Most recently, she was an audit partner with Deloitte & Touche. Currently, she is also a trustee for Delta Dental Plan of Colorado.


 

Steve Molyneuxhas joined the scientific and educational advisory board of GeneEd, the company said yesterday. He is the founder and director of The Learning Lab, a UK-based center that promotes the use of IT technology in education. Molyneux holds undergraduate and graduate degrees in science and education. San Francisco-based GeneEd provides electronic learning tools for the life sciences.


 

F. Mark Modzelewski has joined the scientific advisory board of Acacia Research's CombiMatrix group. He is the founder and executive director of the Nanobusiness Alliance. Modzelewski has degrees from the University of Denver College of Law and from Boston University.


 

George Jackowski, CEO, CSO and chairman of Toronto-based Syn X Pharma, and Rod Wilson, Syn X's president and COO, are expected to join the management team of Nanogen, pending the company's proposed acquisition of Syn X, Nanogen said yesterday. The acquisition is subject to Syn X shareholder approval and other conditions.

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.